Table 1.

Demographic characteristics of all patients (n =159) with allo-HSCT.

Male sex	94 (59.1)
Age, years, mean (SD)	47.8 (±12.7)
Underlying hematologic disease
Leukaemia	82 (51.6)
Lymphoma	34 (21.4)
Myelodysplastic syndrome	26 (16.4)
Multiple myeloma	8 (5)
Other pathologies	9 (5.7)
Type of allo-HSCT
Peripheral blood	151 (95)
Bone marrow	6 (3.8)
Umbilical cord	2 (1.3)
Median (IQR) days of neutropenia (< 500 cells x 109/L)	16 (12 – 20)
Patients with neutropenia (< 500 cells x 109/L) during > 10 days	130 (81.8)

Results are expressed in n (%) unless otherwise stated. Allo-HSCT: allogeneic hematopoietic stem cell transplantation